PREPARATION POTENTIATING RADIATION THERAPY Russian patent published in 2011 - IPC A61K31/513 A61K31/7072 A61P35/00 A61P43/00 C07D403/06 

Abstract RU 2435587 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to potentiating preparation for radiation therapy, which as effective component contains uracyl derivative, represented by formula (1) where R1 represents halogen atom or cyanogroup; and R2 represents (4-8)-member heterocyclic group, which has from 1 to 3 nitrogen atoms and optinally has as substituent C1-C4 alkyl group, iminogroup, hydroxyl group, hydroxymethyl group, methansulphonyloxy group or aminogroup; amidinothiogroup, in which hydrogen atom, bound to nitrogen atom, can be substituted by C1-C4 alkyl group; guanidinogroup, in which hydrogen atom, bound to nitrogen atom, can be substituted by C1-C4 alkyl group or cyanogroup; C1-C4 alkylamidinogroup; or 1-pyrrolidinylmethyl group or its pharmaceutically acceptable salt. Invention also relates to method of radiation therapy potentiation, and to method of cancer treatment, which include introduction of described above uracyl derivative of formula (1) to patient who needs it.

EFFECT: invention ensures reduction of negative effect of radiation therapy, reduction of radiotherapy dose and enhancement of therapeutic effect.

18 cl, 3 tbl, 1 dwg, 4 ex

Similar patents RU2435587C2

Title Year Author Number
REINFORSING AGENT FOR RADIATION THERAPY, WHICH INCLUDES PYRIDINE DERIVATIVE AS ACTIVE INGREDIENT 2006
  • Fukusima Masakazu
RU2415670C2
ANTICANCER AGENT AND METHOD FOR PREDICTION OF THERAPEUTIC EFFECT FOR PATIENTS WITH COLON CANCER AND RECTUM GENE MUTATION KRAS 2012
  • Ito Masanobu
  • Okabe Khiroyuki
RU2585528C2
ANTICANCER MEDICINE, CONTAINING α,α,α-TRIFLUOROTHYMIDINE AND THYMIDINE PHOSPHORYLASE INHIBITOR 2006
  • Emura Tomokhiro
  • Mita Akira
RU2394581C2
APPLICATION OF TRISUBSTITUTED GLYCEROL COMPOUNDS FOR TREATMENT OF RADIOLESIONS 2007
  • Rikhter Vol'Fgang
  • Veber Lutts
RU2448973C2
COMBINED THERAPY FOR CANCER TREATMENT 2015
  • Bao, Xingfeng
  • Albu, Diana
  • Woodall-Jappe, Mary
RU2708374C2
USE OF SESQUITERPENE LACTONE COMPOUND IN PREPARING DRUGS FOR RELIEVING RADIATION-INDUCED INJURIES 2021
  • Chen, Yue
  • Tsaj, Dunpo
  • Bao, Shitsi
  • Chzhan, Syuemej
  • Chen, Tszin
  • Gun, Tszyanmyao
  • Go, Tszyanshuan
  • Li, Tszin
RU2822760C1
COMBINATION OF TRIFLURIDINE/TIPIRACIL HYDROCHLORIDE, ANTITUMOR PLATINUM COMPLEX, AND MODULATOR OF CONTROL POINTS OF IMMUNE RESPONSE 2018
  • Abastado Jean-Pierre
  • Amellal Nadia
  • Bruno Alain
  • Burbridge Michael Frank
  • Cattan Valerie
  • Leger Catherine
RU2778887C2
REMEDY POTENTIATING ANTI-TUMOUR EFFECT, AND ANTI-TUMOUR REMEDY 2004
  • Utida Dzundzi
  • Sudo Kojo
RU2334517C2
ANTITUMOUR AGENT INCLUDING IRINOTECAN HYDROCHLORIDE HYDRATE 2014
  • Okabe Khiroyuki
RU2657604C2
LOW-DOSE ANTITUMOR AGENT INCLUDING IRINOTECAN HYDROCHLORIDE HYDRATE 2014
  • Okabe Khiroyuki
RU2668125C2

RU 2 435 587 C2

Authors

Fukusima Masakazu

Dates

2011-12-10Published

2007-06-28Filed